Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 39282902

Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2025 Jan 2
First author
Apolo AB

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Apolo AB
      type
      Author
    2. name
      Ballman KV
      type
      Author
    3. name
      Sonpavde G
      type
      Author
    4. name
      Berg S
      type
      Author
    5. name
      Kim WY
      type
      Author
    6. name
      Parikh R
      type
      Author
    7. name
      Teo MY
      type
      Author
    8. name
      Sweis RF
      type
      Author
    9. name
      Geynisman DM
      type
      Author
    10. name
      Grivas P
      type
      Author
    11. name
      Chatta G
      type
      Author
    12. name
      Reichert ZR
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Apolo AB
      type
      Author
    2. name
      Ballman KV
      type
      Author
    3. name
      Sonpavde G
      type
      Author
    4. name
      Berg S
      type
      Author
    5. name
      Kim WY
      type
      Author
    6. name
      Parikh R
      type
      Author
    7. name
      Teo MY
      type
      Author
    8. name
      Sweis RF
      type
      Author
    9. name
      Geynisman DM
      type
      Author
    10. name
      Grivas P
      type
      Author
    11. name
      Chatta G
      type
      Author
    12. name
      Reichert ZR
      type
      Author
    bibliography ids
    1. nci-bib-d386562c6586959bb82a8d99
    book metadata
    content sha256
    198053b3292add238ed37f2a96859ea632da508024dde32de50df3b326647d80
    document type
    citation
    dois
    1. 10.1056/NEJMoa2401726
    electronic publication date
    display
    2024 Sep 15
    precision
    day
    year
    2024
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:39282902
    immutable id
    pubmed:39282902@198053b3292add238ed37f2a96859ea632da508024dde32de50df3b326647d80
    journal
    abbreviation
    N Engl J Med
    issn electronic
    1533-4406
    issn print
    0028-4793
    issue
    1
    name
    The New England journal of medicine
    nlm unique id
    0255562
    pages
    45-55
    volume
    392
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      39282902
      provenance
      batch id
      3e43afde6f26fc8df6da
      provider
      NCBI PubMed ESummary
      record sha256
      4e94778bd5f4f38cf406ada1b4da06a4c9d74bfdd12c6923ad9e698c297ce93d
      response sha256
      fa51c3b310a444d84ada833c4cda53c9e4e97161ab5048020b99c51e56e843d2
      retrieved at
      2026-09-09T23:48:21.145285+00:00
      publication date
      display
      2025 Jan 2
      precision
      day
      year
      2025
      publication types
      1. Journal Article
      2. Randomized Controlled Trial
      3. Clinical Trial, Phase III
      4. Multicenter Study
      5. Comparative Study
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/39282902/
      title
      Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma.

      Preserved source evidence · Not medical advice